LI Yan, CHENG Hongjie, SUN Jing, et al. Effects of Anshen Ningxin Capsule on Estrogen Secretion and Related Metabolic Indicators in Patients with Perimenopausal Metabolic Syndrome. [J]. 21(8):934-937(2021)
DOI:
LI Yan, CHENG Hongjie, SUN Jing, et al. Effects of Anshen Ningxin Capsule on Estrogen Secretion and Related Metabolic Indicators in Patients with Perimenopausal Metabolic Syndrome. [J]. 21(8):934-937(2021) DOI: 10.14009/j.issn.1672-2124.2021.08.009.
Effects of Anshen Ningxin Capsule on Estrogen Secretion and Related Metabolic Indicators in Patients with Perimenopausal Metabolic Syndrome
OBJECTIVE: To probe into the efficacy of Anshen Ningxin capsule on the perimenopausal metabolic syndrome
and its effect on estrogen secretion level and metabolism-related indicators. METHODS: Totally 140 patients with perimenopausal metabolic syndrome( liver-depression and spleen-deficiency type) admitted into Xintai Hospital of Traditional Chinese Medicine from 2018 to 2019 were selected and divided into control group and observation group via the random number table
with 70 cases in each group. The control group was given estradiol valerate and dydrogesterone orally
while the observation group was treated with Anshen Ningxin capsule on the basis of control group. The traditional Chinese medicine( TCM) syndrome integral
TCM syndrome efficacy
estrogen secretion level[estradiol( E2)
leuteinizing hormone( LH) and follicle-stimulating hormone( FSH) ]
fasting blood glucose
fasting blood lipid [triglyceride( TG) and high density lipoprotein-cholesterol( HDL-C) ]
waist circumference( WC)
body mass index( BMI)
blood pressure [systolic pressure( SP)
diastolic pressure( DP) ] before and after treatment were compared between two groups. RESULTS: After treatment
the TCM syndrome integral of two groups were significantly decreased
the secretion levels of E2
FSH and LH were significantly improved
the fasting blood glucose
TG
BMI
WC
SP and DP levels were significantly decreased
while the HDL-C was significantly increased
with statistically significant differences( P<0. 05); all the above indicators in observation group were significantly better than those of the control group
with statistically significant differences( P<0. 05). After treatment
the total effective rate of TCM syndromes in the observation group was 90. 0%( 63/70)
which was significantly higher than that of the control group( 74. 3%
52/70)
with statistically significant difference( P < 0. 05). CONCLUSIONS: The efficacy of Anshen Ningxin capsule in the treatment of perimenopausal metabolic syndrome( liver-depression and spleen-deficiency type)is remarkable
which can regulate estrogen secretion level
and interfere with metabolism-related indicators.
关键词
安神宁心胶囊围绝经期女性代谢综合征肝郁脾虚雌激素
Keywords
Anshen Ningxin capsulePerimenopausal womenMetabolic syndromeLiver-depression and spleen-deficiencyEstrogen